One of the critical challenges in managing diabetes in LMICs is the use of insulin therapy, particularly given the complexity of care for monitoring glucose levels, insulin dose adjustments and shortages, poor access to refrigeration and glucose self-monitoring devices and test strips, and high rates of severe hypoglycemia in the context of food insecurity in many LMICs [4]. This evidence concerns the gene INS and Hypoglycemia.